Dick Gephardt - Activities Since Leaving Congress

Activities Since Leaving Congress

On January 3, 2005, Gephardt's three-decade political career ended with the expiration of his fourteenth term in the House of Representatives. That month, Gephardt started a consulting and lobbying firm, Gephardt Group; he is currently its President and CEO. Gephardt also joined the international law firm DLA Piper as strategic advisor in the government affairs practice group between June 2005 and December 2009.

In his new role as a Washington lobbyist, Gephardt, on behalf of the Republic of Turkey, has been actively lobbying against the House resolution condemning the Armenian genocide of 1915 in the Ottoman Empire. While supportive of the resolution while in Congress, he now contends that facts need to be better known before any position is taken over this historical controversy.

Gephardt joined the EMBARQ Corporation Board of Directors in June 2007.

In July 2007, Gephardt endorsed Hillary Rodham Clinton's campaign for president, leading some to speculate that he was interested in running for vice president in 2008. DLA Piper become a major donor to Clinton's campaign, donating about $190,000. Gephardt's name was mentioned by the media during the summer of 2008 as a possible vice presidential choice for eventual nominee Senator Barack Obama.

A collection of Gephardt's congressional documents, dating from 1994 to 2004, was processed from 2006 to 2007 by the Missouri Historical Society for academic use, with a grant through the Institute of Museum and Library Services. In 2005, Washington University in St. Louis inaugurated the Richard A. Gephardt Institute of Public Service, which promotes volunteerism and community activism.

Since 2007, Gephardt began serving on the advisory board of the Extend Health insurance company, and then became a member of its board of directors. In 2009, Gephardt advised UnitedHealth Group, one of America's largest private insurers, in waging a strong campaign against a public option for national health care.

Gephardt has also been significantly involved with the pharmaceutical industry. In addition to a large lobbying contract with the Medicines Company, Gephardt serves as chair of the Council for American Medical Innovation (CAMI), formed by and affiliated with PhRMA. In this capacity he hired his own firm to lobby for the organization, to push to extend patents and block generic drugs from the market.

Gephardt has also served as a lobbyist for Boeing. He is a labor consultant for Spirit Aerosystems and sits on its board of directors. In these roles, Mr. Gephardt has presided over an aggressive anti-union campaign that has bewildered many of his traditional political allies. In July 2011, Spirit Aerosystems walked out of negotiations with the union that represents its engineering, technical and professional workforce. The union subsequently voted the company's last contract offer receiving a 96.5% rejection vote. The company did not change its contract offer significantly after this rejection and relations with its workforce have been contentious ever since. With negotiations at a standstill, production schedules for 2011 and 2012 are threatened.

In 2009, Gephardt was named to the Board of Directors of the Ford Motor Company.

Gephardt currently serves as a Senior Fellow at the Bipartisan Policy Center.